未知生产厂商
Mitemcinal (GM-611) is a novel erythromycin-derived prokinetic agent that acts as an agonist at the motilin receptor.
Mitemcinal (GM-611) is a novel erythromycin-derived prokinetic agent that acts as an agonist at the motilin receptor.
Mitemcinal, an oral motilin agonist, accelerates gastric emptying.
Investigated for use/treatment in gastroparesis and irritable bowel syndrome (IBS).
